FDA Inspection 1218474 — Athena Bioscience, LLC
The FDA completed an inspection of Athena Bioscience, LLC on Sep 6, 2023 in Watkinsville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 6, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Watkinsville, GA (United States)
Additional details
Risk Evaluation and Mitigation Strategies (REMS)